Terms And Conditions
  1. Home
  2. Terms And Conditions
Alcidion Group Limited (ASX: ALC): Targeting ...
By ACE Investors / 21 Nov 2024
Read More
Bluebird Bio Inc. (NASDAQ: BLUE): Announced a...
By ACE Investors / 20 Nov 2024
Read More
Amgen Inc (NASDAQ: AMGN): Delivered a 22% YoY...
By ACE Investors / 18 Nov 2024
Read More
MedAdvisor Ltd (ASX: MDR): MedAdvisor deliver...
By ACE Investors / 18 Nov 2024
Read More
Jazz Pharmaceuticals plc (NASDAQ: JAZZ): Jazz...
By ACE Investors / 15 Nov 2024
Read More
Centene Corporation (NASDAQ: CNC): Delivered ...
By ACE Investors / 08 Nov 2024
Read More
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)...
By ACE Investors / 07 Nov 2024
Read More
Enovis Corp. (NYSE: ENOV): An expanded Recon ...
By ACE Investors / 06 Nov 2024
Read More
Trajan Group Holdings Limited (ASX: TRJ): Ach...
By ACE Investors / 05 Nov 2024
Read More
Dimerix Limited (ASX: DXB): Dimerix and Taiba...
By ACE Investors / 04 Nov 2024
Read More
Microba Life Sciences Limited (ASX: MAP): Com...
By ACE Investors / 04 Nov 2024
Read More
Aroa Biosurgery Ltd (ASX: ARX): Focused on in...
By ACE Investors / 01 Nov 2024
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors